Hualan Biological Engineering Inc. (SHE:002007)
China flag China · Delayed Price · Currency is CNY
14.46
+0.04 (0.28%)
May 6, 2026, 3:04 PM CST

SHE:002007 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
4,4794,5844,3665,3334,5034,426
Other Revenue
10.9310.9313.588.913.6710.31
4,4904,5954,3795,3424,5174,436
Revenue Growth (YoY)
0.67%4.93%-18.02%18.26%1.82%-11.69%
Cost of Revenue
2,0132,0131,7681,7271,6991,538
Gross Profit
2,4762,5822,6113,6152,8182,898
Selling, General & Admin
1,0351,0401,0661,4651,2051,011
Research & Development
330.51337.46333.18280.84314.7253.63
Other Operating Expenses
51.9341.4638.3544.6241.7536.17
Operating Expenses
1,4421,4531,4321,8051,5951,312
Operating Income
1,0341,1301,1791,8101,2231,586
Interest Expense
-7.6-10.24-12.95-13.17-30.27-21.72
Interest & Investment Income
66.0672.59157.95164.47128.9285.28
Currency Exchange Gain (Loss)
0.250.25-0.15-0.3-0.010.33
Other Non Operating Income (Expenses)
3.2-0.55-0.49-0.28-0.38-0.34
EBT Excluding Unusual Items
1,0961,1921,3231,9611,3221,650
Gain (Loss) on Sale of Investments
13.7915.1732.9460.5436.1126.86
Gain (Loss) on Sale of Assets
2.592.890.0844.4447.670.42
Asset Writedown
-4.37-3.53-5.71-9.71-1.19-3.23
Other Unusual Items
-29.61-32.77-11.8121.2424.1714.39
Pretax Income
1,0781,1731,3392,0781,4281,688
Income Tax Expense
159.52173.36183.14315.96180.76234.13
Earnings From Continuing Operations
918.76999.991,1551,7621,2481,454
Minority Interest in Earnings
-61.14-59.59-67.62-280.11-171.34-155.22
Net Income
857.61940.41,0881,4821,0761,299
Net Income to Common
857.61940.41,0881,4821,0761,299
Net Income Growth
-24.72%-13.55%-26.57%37.66%-17.14%-19.48%
Shares Outstanding (Basic)
1,8261,8261,8261,8241,8251,821
Shares Outstanding (Diluted)
1,8261,8261,8291,8241,8281,831
Shares Change (YoY)
-0.13%-0.16%0.23%-0.19%-0.17%0.59%
EPS (Basic)
0.470.520.600.810.590.71
EPS (Diluted)
0.470.520.590.810.590.71
EPS Growth
-24.62%-13.41%-26.75%37.92%-17.00%-19.95%
Free Cash Flow
676.24680.65803.92592.43563.36621.15
Free Cash Flow Per Share
0.370.370.440.330.310.34
Dividend Per Share
1.0001.0000.2000.3000.3000.200
Dividend Growth
400.00%400.00%-33.33%-50.00%-33.33%
Gross Margin
55.16%56.19%59.62%67.67%62.38%65.33%
Operating Margin
23.03%24.58%26.92%33.89%27.08%35.76%
Profit Margin
19.10%20.47%24.84%27.73%23.83%29.28%
Free Cash Flow Margin
15.06%14.81%18.36%11.09%12.47%14.00%
EBITDA
1,3111,4031,4392,0691,4961,783
EBITDA Margin
29.21%30.54%32.87%38.74%33.12%40.18%
D&A For EBITDA
277.24273.88260.46259.05272.5196.39
EBIT
1,0341,1301,1791,8101,2231,586
EBIT Margin
23.03%24.58%26.92%33.89%27.08%35.76%
Effective Tax Rate
14.79%14.77%13.68%15.21%12.65%13.87%
Revenue as Reported
4,4904,5954,3795,3424,5174,436
Advertising Expenses
-5.425.086.312.843.38
Source: S&P Global Market Intelligence. Standard template. Financial Sources.